ES2909102T3 - Usos de fibra de maíz soluble para aumentar poblaciones de bacterias colónicas y aumentar la absorción de minerales - Google Patents

Usos de fibra de maíz soluble para aumentar poblaciones de bacterias colónicas y aumentar la absorción de minerales Download PDF

Info

Publication number
ES2909102T3
ES2909102T3 ES14721678T ES14721678T ES2909102T3 ES 2909102 T3 ES2909102 T3 ES 2909102T3 ES 14721678 T ES14721678 T ES 14721678T ES 14721678 T ES14721678 T ES 14721678T ES 2909102 T3 ES2909102 T3 ES 2909102T3
Authority
ES
Spain
Prior art keywords
composition
corn fiber
parabacteroides
soluble corn
populations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14721678T
Other languages
English (en)
Spanish (es)
Inventor
Connie Weaver
Cindy Nakatsu
Patricia Williamson
Andrew Hoffman
Lisa Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Tate and Lyle Solutions USA LLC
Original Assignee
Purdue Research Foundation
Tate and Lyle Solutions USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49081352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2909102(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Purdue Research Foundation, Tate and Lyle Solutions USA LLC filed Critical Purdue Research Foundation
Application granted granted Critical
Publication of ES2909102T3 publication Critical patent/ES2909102T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES14721678T 2013-03-22 2014-03-22 Usos de fibra de maíz soluble para aumentar poblaciones de bacterias colónicas y aumentar la absorción de minerales Active ES2909102T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361804584P 2013-03-22 2013-03-22
PCT/US2014/031526 WO2014153554A1 (en) 2013-03-22 2014-03-22 Uses of soluble corn fiber for increasing colonic bacteria populations and increasing mineral absorption

Publications (1)

Publication Number Publication Date
ES2909102T3 true ES2909102T3 (es) 2022-05-05

Family

ID=49081352

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14721678T Active ES2909102T3 (es) 2013-03-22 2014-03-22 Usos de fibra de maíz soluble para aumentar poblaciones de bacterias colónicas y aumentar la absorción de minerales

Country Status (8)

Country Link
US (2) US11129403B2 (OSRAM)
EP (2) EP4035734A1 (OSRAM)
JP (2) JP6712715B2 (OSRAM)
KR (1) KR102362975B1 (OSRAM)
CN (2) CN114468303A (OSRAM)
ES (1) ES2909102T3 (OSRAM)
GB (1) GB201312713D0 (OSRAM)
WO (1) WO2014153554A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013139861A1 (en) 2012-03-20 2013-09-26 Luc Montagnier Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
US20200245667A1 (en) * 2017-09-13 2020-08-06 Evolve Biosystems, Inc. Oligosaccharide compositions and their use during transitional phases of the mammalian gut microbiome
WO2019106620A1 (en) * 2017-11-30 2019-06-06 Glycom A/S Human milk oligosaccharides and synthetic compositions thereof for microbiota modulation
KR20220100875A (ko) * 2019-10-14 2022-07-18 테이트 앤드 라일 솔루션스 유에스에이 엘엘씨 향미 변화 및/또는 단맛 강화 조성물 및 방법 및 이에 기초한 식품 및 음료 제품
EP4460368A1 (en) * 2021-06-22 2024-11-13 Muhammed Majeed Calebin-a for thermogenesis and dysbiosis
WO2023176952A1 (ja) 2022-03-18 2023-09-21 株式会社明治 腸管内での細菌の増殖制御用組成物及びその利用
EP4518669A1 (en) 2022-05-06 2025-03-12 Tate & Lyle Solutions USA LLC Low sugar, high fiber chewable sweets
CN120699879A (zh) * 2025-09-01 2025-09-26 美益添生物医药(武汉)有限公司 副普雷沃氏菌的增菌剂、增菌培养基及应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS61219392A (ja) 1985-03-25 1986-09-29 Showa Sangyo Kk 高温度縮合反応による分岐オリゴ糖シラツプの製造方法
JPS63109791A (ja) 1986-10-27 1988-05-14 Showa Sangyo Co Ltd 分岐オリゴ糖シラツプの連続的製法
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
JPH03175989A (ja) 1989-12-01 1991-07-31 Chiyoda Corp 分岐オリゴ糖シラップ及びその製造方法
US6023797A (en) * 1997-04-01 2000-02-15 Brumfield; John David Comfort beach towel with inflatable pillow
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20030077255A1 (en) * 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
KR100875576B1 (ko) 2001-04-27 2008-12-23 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 이소말토오스의 제조방법 및 용도
DE60231322D1 (de) 2001-11-12 2009-04-09 Mars Inc Nahrungsmittel für katzen und hunde
GB0229015D0 (en) † 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
MXPA06001722A (es) 2003-08-14 2006-05-19 Bio Balance Corp Cepas de bacterias, composiciones que las incluyen y el uso de probioticos de las mismas.
US7759105B2 (en) 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050095350A1 (en) 2003-09-22 2005-05-05 Grain Processing Corporation Nutritive food source including controlled energy release carbohydrate
GB0414655D0 (en) 2004-06-30 2004-08-04 Leuven K U Res & Dev Prebiotic
US20060210696A1 (en) 2005-03-17 2006-09-21 Chi-Li Liu Slowly digestible carbohydrate
CN101291597A (zh) * 2005-10-24 2008-10-22 雀巢技术公司 膳食纤维制剂和施用方法
US8530447B2 (en) * 2005-10-24 2013-09-10 Nestec S.A. Dietary fiber formulation and method of administration
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7608436B2 (en) † 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
FR2897869B1 (fr) † 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
CN101095698B (zh) 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US20080292766A1 (en) 2007-05-23 2008-11-27 Hoffman Andrew J Edible Composition Comprising a Slowly Digestible or Digestion Resistant Oligosaccharide Composition
CN101492997A (zh) * 2008-01-21 2009-07-29 姚小林 液压潜孔凿岩冲击器
EP2320749B1 (en) 2008-08-04 2015-09-16 DSM IP Assets B.V. Production of beadlets comprising probiotic compounds
CN101744239A (zh) 2008-12-01 2010-06-23 青岛东海药业有限公司 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
CN101537020B (zh) 2009-04-24 2012-05-02 东北制药集团公司沈阳第一制药厂 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂
US20120129794A1 (en) † 2009-07-24 2012-05-24 Dowd Scot E Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
WO2011043654A1 (en) † 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
WO2011060123A1 (en) * 2009-11-12 2011-05-19 Nestec S.A. Nutritional composition for promoting gut microbiota balance and health
CN102939392A (zh) † 2010-03-01 2013-02-20 国家农艺研究院 肥胖的诊断方法
WO2012024638A2 (en) † 2010-08-20 2012-02-23 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
CA2808495A1 (en) * 2010-08-25 2012-03-01 Tate & Lyle Ingredients Americas Llc Synbiotic product
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
WO2012104840A2 (en) † 2011-02-03 2012-08-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. High molecular ordered fibrilar structures method for their preparation and uses thereof
MX2014005433A (es) 2011-11-04 2014-08-22 Gen Mills Inc Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
EP2850202B1 (en) * 2012-05-18 2020-03-11 Genome Research Limited Methods and groups
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption

Also Published As

Publication number Publication date
KR20150135417A (ko) 2015-12-02
US20220225654A1 (en) 2022-07-21
GB201312713D0 (en) 2013-08-28
KR102362975B1 (ko) 2022-02-15
CN114468303A (zh) 2022-05-13
JP7055162B2 (ja) 2022-04-15
JP2016515388A (ja) 2016-05-30
JP2020120675A (ja) 2020-08-13
CN105473004A (zh) 2016-04-06
EP2981180B1 (en) 2021-12-29
EP2981180B2 (en) 2025-08-13
JP6712715B2 (ja) 2020-06-24
WO2014153554A1 (en) 2014-09-25
EP2981180A1 (en) 2016-02-10
EP4035734A1 (en) 2022-08-03
US11129403B2 (en) 2021-09-28
US20160058056A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
ES2909102T3 (es) Usos de fibra de maíz soluble para aumentar poblaciones de bacterias colónicas y aumentar la absorción de minerales
Megur et al. Prebiotics as a tool for the prevention and treatment of obesity and diabetes: classification and ability to modulate the gut microbiota
Plaza-Diaz et al. Plausible biological interactions of low-and non-calorie sweeteners with the intestinal microbiota: an update of recent studies
Rocha et al. On the valorization of lactose and its derivatives from cheese whey as a dairy industry by-product: an overview
Salvatore et al. Dietary fibers in healthy children and in pediatric gastrointestinal disorders: a practical guide
Varzakas et al. Sweeteners: nutritional aspects, applications, and production technology
Lu et al. Tagatose, a new antidiabetic and obesity control drug
Tennyson et al. Microecology, obesity, and probiotics
Gultekin et al. Food additives and microbiota.
ES2824679T5 (es) Mezclas de oligosacáridos de la leche humana
Klosterbuer et al. Gastrointestinal effects of resistant starch, soluble maize fibre and pullulan in healthy adults
US11058711B2 (en) Use of resistant potato starch as a prebiotic to modify microbiota
CN115804798A (zh) 含微生物的组合物增加丁酸、叶酸或烟酸的肠道生产和/或降低琥珀酸的肠道生产的应用
Sebastián et al. Prebiotics in beverages: from health impact to preservation
François et al. Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan–oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trial
Uyeno et al. Changes in mouse gastrointestinal microbial ecology with ingestion of kale
US20230034247A1 (en) Method and composition for treating or decreasing gut microbiome dysbiosis induced by a prior antibiotic treatment
CN113939301A (zh) 人乳寡糖用于在患有非乳糜泻小麦和/或麸质敏感性患者中治疗症状
US20250312388A1 (en) Bifidobacterium infantis formulations
CN101347229A (zh) 一种具有润肠通便功能的保健食品及生产方法
on Nutrition et al. Safety of cellobiose as a novel food pursuant to regulation (EU) 2015/2283
Del Pozo de La Calle et al. Potential Effects of Sucralose and Saccharin on Gut Microbiota: A Review
Podder et al. The Significance of Food Fortification for Prevention of Major Health Challenges Due to Micronutrient Deficiencies (MND) for Under 5 Years Children in Bangladesh
CN121013657A (zh) 用于在个体中使用以支持脑发育和/或认知发育的包含人乳低聚糖的组合物
Lee et al. Lactose: Uses in Industry and Biomedical Importance Lactose a Functional Disaccharide